Ignite Creation Date:
2024-05-05 @ 11:26 AM
Last Modification Date:
2024-10-26 @ 9:07 AM
Study NCT ID:
NCT00044031
Status:
COMPLETED
Last Update Posted:
2014-04-17
First Post:
2002-08-16
Brief Title:
Safety and Efficacy of G17DT Immunogen Combined With Gemcitabine vs Gemcitabine in the Treatment of Advanced Pancreatic Carcinoma
Sponsor:
Cancer Advances Inc
Organization:
Cancer Advances Inc
Organization Data
Organization:
Cancer Advances Inc
Class:
INDUSTRY
Study ID:
PC4
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Cancer Advances Inc
Lead Sponsor Class:
INDUSTRY
Responsible Party:
None
Responsible Party Title:
None
Responsible Party Type:
SPONSOR
Responsible Party Affiliation:
None
Old Name:
None
Old Organization:
None